Page last updated: 2024-09-04
esorubicin and Hepatocellular Carcinoma
esorubicin has been researched along with Hepatocellular Carcinoma in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Cnaan, A; Dayal, Y; Falkson, G; Falkson, H; Haller, DG; Simson, IW; Smith, TJ | 1 |
Trials
1 trial(s) available for esorubicin and Hepatocellular Carcinoma
Article | Year |
---|---|
A randomized phase II study of acivicin and 4'deoxydoxorubicin in patients with hepatocellular carcinoma in an Eastern Cooperative Oncology Group study.
Topics: Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Doxorubicin; Drug Administration Schedule; Female; Humans; Isoxazoles; Liver Neoplasms; Male; Prospective Studies; Survival Rate | 1990 |